Seer (SEER) Enterprise Value (2020 - 2026)
Seer (SEER) posted quarterly Enterprise Value of -$166.7 million for Q1 2026, up 30.47% year-over-year from -$127.7 million in Q1 2025, and up 10.34% quarter-over-quarter from -$185.9 million in Q4 2025.
Seer (SEER) Enterprise Value (2020 - 2026) Analysis & Trends
Seer's Enterprise Value history runs 7 years deep, the most recent figure standing at -$166.7 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 30.47% year-over-year to -$166.7 million; the TTM figure through Mar 2026 stood at -$166.7 million (up 30.47% YoY), while the FY2025 annual figure was -$185.9 million, up 21.37% from the prior year.
- Enterprise Value for Q1 2026 stood at -$166.7 million, up from -$185.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$166.7 million in Q1 2026, with the low at -$451.2 million in Q2 2022.
- The 5-year median for Enterprise Value is -$308.6 million (2024), against an average of -$303.0 million.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value decreased 5.29% in 2022, then surged 30.47% in 2026.
- Seer's Enterprise Value stood at -$421.2 million in 2022, then advanced by 24.93% to -$316.2 million in 2023, then increased by 25.24% to -$236.4 million in 2024, then increased by 21.37% to -$185.9 million in 2025, then climbed by 10.34% to -$166.7 million in 2026.
- Business Quant data shows SEER's Enterprise Value at -$166.7 million in Q1 2026, -$185.9 million in Q4 2025, and -$199.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -152.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -152.85 Mn |
| Mar 31, 2026 | -166.67 Mn |
| Dec 31, 2025 | -185.90 Mn |
| Sep 30, 2025 | -199.24 Mn |
| Jun 30, 2025 | -209.83 Mn |
| Mar 31, 2025 | -239.73 Mn |
| Dec 31, 2024 | -236.41 Mn |
| Sep 30, 2024 | -247.60 Mn |
| Jun 30, 2024 | -283.45 Mn |
| Mar 31, 2024 | -308.55 Mn |
| Dec 31, 2023 | -316.22 Mn |
| Sep 30, 2023 | -331.25 Mn |
| Jun 30, 2023 | -320.21 Mn |
| Mar 31, 2023 | -352.09 Mn |
| Dec 31, 2022 | -421.24 Mn |
| Sep 30, 2022 | -436.06 Mn |
| Jun 30, 2022 | -451.19 Mn |
| Mar 31, 2022 | -445.23 Mn |
| Dec 31, 2021 | -400.07 Mn |
| Sep 30, 2021 | -506.60 Mn |